CG Oncology reports positive first results from the CORE-008 Cohort CX Phase 2 trial of cretostimogene with gemcitabine in high-risk NMIBC by thaan@22fillmore.com | May 15, 2026 | Portfolio News
Ceribell completes commercial launch of seizure monitoring for newborns and children and activates first sites in its delirium detection pilot by thaan@22fillmore.com | May 11, 2026 | Portfolio News
Mobia Medical prices $150M initial public offering and begins trading on Nasdaq under the ticker MOBI by thaan@22fillmore.com | May 7, 2026 | Portfolio News
Veradermics announces positive Phase 3 Study 302 topline results for VDPHL01 in male pattern hair loss by mariel | Apr 27, 2026 | Portfolio News
Mirum Pharmaceuticals announces primary endpoint met in Phase 2b portion of the AZURE-1 Study of brelovitug in chronic hepatitis delta virus by mariel | Apr 27, 2026 | Portfolio News
